Treating Type 2 Diabetes by Treating Obesity. Vijaya Surampudi, MD, MS Assistant Professor of Medicine Center for Human Nutrition

Size: px
Start display at page:

Download "Treating Type 2 Diabetes by Treating Obesity. Vijaya Surampudi, MD, MS Assistant Professor of Medicine Center for Human Nutrition"

Transcription

1

2 Treating Type 2 Diabetes by Treating Obesity Vijaya Surampudi, MD, MS Assistant Professor of Medicine Center for Human Nutrition 2

3 Center Stage Obesity is currently an epidemic in the United States, with almost 70% of Americans overweight and one of three obese.

4 Age-adjusted Prevalence of Obesity and Diagnosed Diabetes Among US Adults Obesity (BMI 30 kg/m 2 ) Diabetes No Data <14.0% 14.0% 17.9% 18.0% 21.9% 22.0% 25.9% > 26.0% No Data <4.5% 4.5% 5.9% 6.0% 7.4% 7.5% 8.9% >9.0% CDC s Division of Diabetes Translation. United States Surveillance System available at

5 Obesity Management was added a few years ago and remained in the Standard of Medical Care in Diabetes

6 The Natural History of Type 2 Diabetes Saisho Y. Postprandial C-Peptide to Glucose Ratio as a Marker of β Cell Function: Implication for the Management of Type 2 Diabetes. Int J Mol Sci May 17;17(5). 6

7 Insulin Resistance Visceral Fat Weight Loss Insulin Sensitivity Glucose Toxicity Lipotoxicity Inflammation Low Carb Exercise VLCD Exercise Insulin Sensitivity Insulin Sensitivity Insulin Sensitivity 7

8 Overweight/Obesity Treatment w/ T2DM Body Mass Index Category (kg/m 2 ) Treatment Diet, physical activity & behavioral therapy 23.0* or * or Pharmacotherapy Metabolic surgery * Asian-American individuals Treatment may be indicated for selected, motivated patients. American Diabetes Association Standards of Medical Care in Diabetes. Obesity management for the treatment of type 2 diabetes. Diabetes Care 2018; 41 (Suppl. 1): S65-S72

9 Evidence for Lifestyle Change There is overwhelming evidence that modest sustained weight loss, for example, current target of 5 10%, prevents the onset of most new T2DM in people with pre-diabetes. It improves all aspects of diabetes control: Hyperglycemia Blood pressure Lipids Reductions in drug doses for medications used to treat hypertension, diabetes and dyslipidemia. 9

10 Nutrition Recommendations for Diabetes Mellitus From Late 19 th Century 1890s: Rice, oatmeal, potato, legume, or porridge diets 1979: American Diabetes Association Carb: 50-60% Protein: 12-20% Fat: <10% as saturated fat 43% Carb 18% Protein 39% Fat <1000 cal 1927: Joslin's "weighed diets s:allen's "starvation" diet Low Carb High Fat Low cal 22% Carb 16% Protein 62% Fat ~ cal 1986: American Diabetes Association Carb: 55-65% Protein: 0.8 g/kg Fat: Total fat <30% 10

11 Number and Percentage of U.S. Population with Diagnosed Diabetes, CDC s Division of Diabetes Translation. United States Diabetes Surveillance System available at

12 Major Randomized Control Trials that looked at Intensive Lifestyle Interventions Diabetes Prevention Program (DPP) Look AHEAD CALERIE 12

13 In the 2.8 years of the Diabetes Prevention Program (DPP) randomized clinical trial, diabetes incidence in high-risk adults was reduced by 58% with intensive lifestyle intervention and by 31% with metformin, compared with placebo. They investigated the persistence of these effects in the long term. All active DPP participants were eligible for continued follow-up of 3150 (88%) enrolled for a median additional follow-up of 5.7 years 13

14 10-year follow-up of Diabetes Incidence and Weight Loss in the Diabetes Prevention Program Outcomes Study 14

15 10-year follow-up of Diabetes Incidence and Weight Loss in the Diabetes Prevention Program Outcomes Study 15

16 16

17 17

18 18

19 19

20 Major Randomized Control Trials that looked at Intensive Lifestyle Interventions Diabetes Prevention Program (DPP) Look AHEAD CALERIE 20

21 In 16 study centers in the United States, they randomly assigned 5145 overweight or obese patients with type 2 diabetes to receive the ILI, which included weekly group and individual counseling in the first 6 months followed by 3 sessions per month for the second 6 months and twice-monthly contact and regular refresher group series and campaigns in years 2 to 4 (n=2241) or the DSE, which was an offer of 3 group sessions per year on diet, physical activity, and social support (n=2262). 21

22 From: Association of an Intensive Lifestyle Intervention With Remission of Type 2 Diabetes JAMA. 2012;308(23): doi: /jama Date of download: 10/5/2017 Copyright 2012 American Medical Association. All rights reserved.

23 N Engl J Med May 8;370(19):1866 In 16 study centers in the United States, we randomly assigned 5145 overweight or obese patients with type 2 diabetes to participate in an intensive lifestyle intervention that promoted weight loss through decreased caloric intake and increased physical activity (intervention group) or to receive diabetes support and education (control group). 23

24 Changes in Weight, Physical Fitness, Waist Circumference, and Glycated Hemoglobin Levels during 10 Years of Follow-up.

25 Major Randomized Control Trials that looked at Intensive Lifestyle Interventions Diabetes Prevention Program (DPP) Look AHEAD CALERIE 25

26 To determine CR s feasibility, safety, and effects on predictors of longevity, disease risk factors, and quality of life in nonobese (BMI 22-28) humans aged years, 218 persons were randomized to a 2-year intervention designed to achieve 25% CR or to AL diet. 26

27 Changes in Weight during a 2 Years of Follow-up. 27

28 Changes in Cholesterol, Triglycerides, Insulin Resistance and Blood Pressure during a 2 Years of Follow-up. 28

29 Overweight/Obesity Treatment w/ T2DM Body Mass Index Category (kg/m 2 ) Treatment Diet, physical activity & behavioral therapy 23.0* or * or Pharmacotherapy Metabolic surgery * Asian-American individuals Treatment may be indicated for selected, motivated patients. American Diabetes Association Standards of Medical Care in Diabetes. Obesity management for the treatment of type 2 diabetes. Diabetes Care 2018; 41 (Suppl. 1): S65-S72

30 Recommendations: Metabolic Surgery Metabolic surgery should be recommended to treat T2DM for all appropriate surgical candidates with BMIs > 40 (37.5*) and those with BMIs ( *) when hyperglycemia is inadequately controlled despite lifestyle & optimal medical therapy. A American Diabetes Association Standards of Medical Care in Diabetes. Obesity management for the treatment of type 2 diabetes. Diabetes Care 2018; 41 (Suppl. 1): S65-S72

31 Types of Surgeries

32

33 Original Article Bariatric Surgery and Prevention of Type 2 Diabetes in Swedish Obese Subjects Lena M.S. Carlsson, M.D., Ph.D., Markku Peltonen, Ph.D., Sofie Ahlin, M.D., Åsa Anveden, M.D., Claude Bouchard, Ph.D., Björn Carlsson, M.D., Ph.D., Peter Jacobson, M.D., Ph.D., Hans Lönroth, M.D., Ph.D., Cristina Maglio, M.D., Ingmar Näslund, M.D., Ph.D., Carlo Pirazzi, M.D., Stefano Romeo, M.D., Ph.D., Kajsa Sjöholm, Ph.D., Elisabeth Sjöström, M.D., Hans Wedel, Ph.D., Per-Arne Svensson, Ph.D., and Lars Sjöström, M.D., Ph.D. N Engl J Med Volume 367(8): August 23, 2012

34 Study Design The SOS study is a nonrandomized, prospective, controlled intervention trial comparing the long-term effects of bariatric surgery with the effects of usual care. All the patients in the surgery and control groups entered this study with the intention of losing weight. In the bariatric-surgery group, 311 participants underwent banding, 1140 vertical banded gastroplasty, and 207 a gastric bypass procedure. Patients in the control group received the customary treatment for obesity at their primary health care centers. 34

35 The Swedish Obesity Study (SOS) 20 year follow Up Data

36 The Swedish Obesity Study (SOS)

37 Three-thousand four-hundred and eighty-five obese individuals receiving bariatric surgery or conventional treatment were grouped into four baseline BMI categories (<35, 35 40, or 45 kg/m2) and five weight-change categories according to their BMI at 2 years. The incidence and remission of diabetes at 2 years was assessed. 37

38 T2D Incidence 38

39 T2D Remission 39

40 Diabetes Care Jul;39(7): An observational cohort of obese participants was studied. Of 2,458 obese participants enrolled, 1,868 (76%) had complete data to assess diabetes status at both baseline and at least one follow-up visit. Of these, 627 participants (34%) were classified with diabetes: 466 underwent RYGBP and 140 underwent LAGB. 40

41 3 Years Follow up Data

42 They assessed outcomes 5 years after 150 patients who had type 2 diabetes and a bodymass index of 27 to 43 were randomly assigned to receive intensive medical therapy alone or intensive medical therapy plus Roux-en-Y gastric bypass or sleeve gastrectomy

43 Schauer PR et al. N Engl J Med 2017;376:

44 Potential Mechanisms of Diabetes Remission after Bariatric Surgery 45

45 GI Tract Largest Endocrine Organ

46 Hormonal change during bariatric surgery Singh AK, Singh R, Kota SK. Bariatric surgery and diabetes remission: Who would have thought it? Indian Journal of Endocrinology and Metabolism. 2015;19(5):

47 Singh AK, Singh R, Kota SK. Bariatric surgery and diabetes remission: Who would have thought it? Indian Journal of Endocrinology and Metabolism. 2015;19(5):

48 Revisiting Diet 49

49 Overweight/Obesity Treatment w/ T2DM Body Mass Index Category (kg/m 2 ) Treatment Diet, physical activity & behavioral therapy 23.0* or * or Pharmacotherapy Metabolic surgery * Asian-American individuals Treatment may be indicated for selected, motivated patients. American Diabetes Association Standards of Medical Care in Diabetes. Obesity management for the treatment of type 2 diabetes. Diabetes Care 2017; 40 (Suppl. 1): S57-S63

50 Recommendations: VLCD Small studies have demonstrated that in obese patients with type 2 diabetes more extreme dietary energy restriction with very-low-calorie diets can reduce A1C to <6.5% (48 mmol/mol) and fasting glucose to <126 mg/dl (7.0 mmol/l) in the absence of pharmacologic therapy or ongoing procedures. 51

51 VLCD Very Low Calorie Diet (VLCD) <800 kcal per day Low Calorie Diet (LCD) >800 kcal per day A VLCD may be used for a short time to promote quick weight loss among some people who are considered to be obese. 52

52 T2D duration of years (n = 30) followed a VLCD for 8 weeks. All oral agents or insulins were stopped Following a stepped return to isocaloric diet, a structured, individualized program of weight maintenance 53

53 Results 54

54 Diabetes 62: , 2013 They studied eleven subjects who underwent RYGB and fourteen subjects mean-matched for BMI, HbA1c, and diabetes duration who were admitted to our inpatient research unit and given a very low calorie diet (VLCD) of 500 kcal/day with a macronutrient content similar to that consumed by patients after RYGB. Frequently sampled intravenous glucose tolerance tests were performed before and after interventions.

55 Beta Cell Function

56 Very Low and Low Calorie Diets Are Effective to Reverse Pre-Diabetes in Ambulatory Care Settings Vijaya Surampudi MD, MS, Xinkai Zhou MS, Chi-Hong Tseng PhD, Zhaoping Li MD, PhD University of California Los Angeles

57 Subjects Total Subjects N=4634 N =2572 Baseline analysis Excluded due to Inclusion/Exclusion: N = 2062 Normal Subjects N=1396 IFG Subjects N=1176 Presented at Endocrine Society 2018 Unpublished Data

58 Percentage Results: Glucose Percentage of patients with normalization of blood glucose <100 mg/dl in relation to amount of weight lost. 60.0% 50.0% 40.0% 30.0% 20.0% 10.0% 0.0% Normalization of Blood Glucose at 3 months <5/<2.2 (5-10)/( ) (10-15)/( ) >=15/>=6.8 Weight Loss (lbs/kgs) Presented at Endocrine Society 2018 Unpublished Data

59 Overweight/Obesity Treatment w/ T2DM Body Mass Index Category (kg/m 2 ) Treatment Diet, physical activity & behavioral therapy 23.0* or * or Pharmacotherapy Metabolic surgery * Asian-American individuals Treatment may be indicated for selected, motivated patients. American Diabetes Association Standards of Medical Care in Diabetes. Obesity management for the treatment of type 2 diabetes. Diabetes Care 2017; 40 (Suppl. 1): S57-S63

60 Conclusion There is overwhelming evidence that modest sustained weight loss, for example, current target of 5 10%, prevents the onset of most new T2DM in people with pre-diabetes. Bariatric surgery is now a suggestion for obese people with T2DM. Surgery carries immediate and long-term risks, and is not acceptable to all people. The metabolic benefits of bariatric surgery have been observed by negative energy balance alone, using a low-energy liquid-formula diets. More studies need to be done but the evidence is growing 61

61 Insulin Resistance Visceral Fat Weight Loss Insulin Sensitivity Glucose Toxicity Lipotoxicity Inflammation Low Carb Exercise VLCD Exercise Insulin Sensitivity Insulin Sensitivity Insulin Sensitivity 62

62

Obesity Management in Patients with Diabetes Jamy D. Ard, MD Sunday, February 11, :15 a.m. 11:00 a.m.

Obesity Management in Patients with Diabetes Jamy D. Ard, MD Sunday, February 11, :15 a.m. 11:00 a.m. Obesity Management in Patients with Diabetes Jamy D. Ard, MD Sunday, February 11, 2018 10:15 a.m. 11:00 a.m. Type 2 diabetes mellitus (T2DM) is closely associated with obesity, primarily through the link

More information

What is Metabolic About Metabolic Surgery? The New ADA Recommendations

What is Metabolic About Metabolic Surgery? The New ADA Recommendations What is Metabolic About Metabolic Surgery? The New ADA Recommendations Obesity Symposium September 16, 2017 Timothy Howland, MD Lourdes Endocrinology Bariatric from the Greek root bar- ("weight" as in

More information

6/10/2016. Bariatric Surgery: Impact on Diabetes and CVD Risk. Disclosures BARIATRIC PROCEDURES

6/10/2016. Bariatric Surgery: Impact on Diabetes and CVD Risk. Disclosures BARIATRIC PROCEDURES Bariatric Surgery: Impact on Diabetes and CVD Risk Anthony M Gonzalez, MD, FACS, FASMBS Medical Director Bariatric Surgery, South Miami Hospital Chief of Surgery, Baptist Hospital of Miami Associate Professor

More information

Other Ways to Achieve Metabolic Control

Other Ways to Achieve Metabolic Control Other Ways to Achieve Metabolic Control Nestor de la Cruz- Muñoz, MD, FACS Associate Professor of Clinical Surgery Chief, Division of Laparoendoscopic and Bariatric Surgery DeWitt Daughtry Family Department

More information

Mr Jon Morrow. General Surgeon Department of Bariatric Surgery Middlemore Hospital. 16:55-17:10 Why Bariatric Surgery?

Mr Jon Morrow. General Surgeon Department of Bariatric Surgery Middlemore Hospital. 16:55-17:10 Why Bariatric Surgery? Mr Jon Morrow General Surgeon Department of Bariatric Surgery Middlemore Hospital 16:55-17:10 Why Bariatric Surgery? Why Bariatric Surgery? Jon Morrow Bariatric Surgery Misconceptions Surgery is a cop

More information

OBESITY 2008: DIET, EXERCISE, DRUGS, AND SURGERY

OBESITY 2008: DIET, EXERCISE, DRUGS, AND SURGERY OBESITY 2008: DIET, EXERCISE, DRUGS, AND SURGERY Robert B. Baron MD MS Professor and Associate Dean UCSF School of Medicine Declaration of full disclosure: No conflict of interest CLASSIFICATION OF OVERWEIGHT

More information

BARIATRIC SURGERY AND TYPE 2 DIABETES MELLITUS

BARIATRIC SURGERY AND TYPE 2 DIABETES MELLITUS BARIATRIC SURGERY AND TYPE 2 DIABETES MELLITUS George Vl Valsamakis European Scope Fellow Obesity Visiting iti Associate Prof Warwick Medical School Diabetes is an increasing healthcare epidemic throughout

More information

type 2 diabetes is a surgical disease

type 2 diabetes is a surgical disease M. Lannoo, MD, University Hospitals Leuven Walter Pories claimed in 1992 type 2 diabetes is a surgical disease Buchwald et al. conducted a large meta-analysis THE FIRST OBSERVATIONS W. Pories 500 patients

More information

Introduction ARTICLE. and 3.4%, respectively. In both the medium- and majorweight-reduction

Introduction ARTICLE. and 3.4%, respectively. In both the medium- and majorweight-reduction Diabetologia (2015) 58:1448 1453 DOI 10.1007/s00125-015-3591-y ARTICLE Incidence and remission of type 2 diabetes in relation to degree of obesity at baseline and 2 year weight change: the Swedish Obese

More information

OBESITY IN PRIMARY CARE

OBESITY IN PRIMARY CARE OBESITY IN PRIMARY CARE Obesity- definition Is a chronic disease In ICD 10 E66 Overweight and obesity are defined as abnormal or excessive fat accumulation that may impair health. Obesity is a leading

More information

Substantial Decrease in Comorbidity 5 Years After Gastric Bypass

Substantial Decrease in Comorbidity 5 Years After Gastric Bypass Substantial Decrease in Comorbidity 5 Years After Gastric Bypass A Population-based Study From the Scandinavian Obesity Surgery Registry Sundbom, Magnus; Hedberg, Jakob; Marsk, Richard; Boman, Lars; Bylund,

More information

Treating Type 2 Diabetes with Bariatric Surgery. Goal of Treating T2DM. Remission of T2DM with Bariatric

Treating Type 2 Diabetes with Bariatric Surgery. Goal of Treating T2DM. Remission of T2DM with Bariatric Treating Type 2 Diabetes with Bariatric Surgery Number (in Millions) of Persons with Diagnosed Diabetes, United States, 198 25 The number of Americans with diabetes increased from 5.6 to 15.8 million Guilherme

More information

Bariatric Surgery vs. Intensive Medical Therapy in Obese Diabetic Patients: 3-Year Outcomes

Bariatric Surgery vs. Intensive Medical Therapy in Obese Diabetic Patients: 3-Year Outcomes Bariatric Surgery vs. Intensive Medical Therapy in Obese Diabetic Patients: 3-Year Outcomes Results of the STAMPEDE Trial Philip R Schauer, Deepak L Bhatt, John P Kirwan, Kathy Wolski, Stacy A Brethauer,

More information

Diabetes Day for Primary Care Clinicians Advances in Diabetes Care

Diabetes Day for Primary Care Clinicians Advances in Diabetes Care Diabetes Day for Primary Care Clinicians Advances in Diabetes Care Elliot Sternthal, MD, FACP, FACE Chair New England AACE Diabetes Day Planning Committee Welcome and Introduction This presentation will:

More information

Current Trends in Bariatric Surgery

Current Trends in Bariatric Surgery Current Trends in Bariatric Surgery 9.28.2017 Abraham Krikhely, MD, FACS, FASMBS Assistant Professor of Surgery, CUMC Center of Minimal Access, Metabolic and Weight Loss Surgery Outline Why consider surgery

More information

Disclosures OBESITY. Overview. Obesity: Definition. Prevalence of Obesity is Rising. Obesity as a Risk Factor. None

Disclosures OBESITY. Overview. Obesity: Definition. Prevalence of Obesity is Rising. Obesity as a Risk Factor. None Disclosures None OBESITY Florencia Halperin, M.D. Medical Director, Program for Management Brigham and Women s Hospital Instructor in Medicine, Harvard Medical School Overview Obesity: Definition Definition

More information

The National Diabetes Prevention Program in Washington State March 2012

The National Diabetes Prevention Program in Washington State March 2012 The National Diabetes Prevention Program in Washington State March 2012 Session Objectives 1. Overview of pre-diabetes. 2. Describe the Diabetes Prevention Program (DPP). 3. Eligibility for the DPP. 4.

More information

CME Post Test. D. Treatment with insulin E. Age older than 55 years

CME Post Test. D. Treatment with insulin E. Age older than 55 years CME Post Test Translational Endocrinology & Metabolism: Metabolic Surgery Update Please select the best answer to each question on the online answer sheet. Go to http://www.endojournals.org/translational/

More information

How do we adapt diet approaches for patients with obesity with or without diabetes? Therese Coleman Dietitian

How do we adapt diet approaches for patients with obesity with or without diabetes? Therese Coleman Dietitian How do we adapt diet approaches for patients with obesity with or without diabetes? Therese Coleman Dietitian Developing a specialist weight management programme How did we adapt dietary approaches for

More information

Bariatric Surgery versus Intensive Medical Therapy for Diabetes 3-Year Outcomes

Bariatric Surgery versus Intensive Medical Therapy for Diabetes 3-Year Outcomes The new england journal of medicine original article Bariatric Surgery versus Intensive Medical for Diabetes 3-Year Outcomes Philip R. Schauer, M.D., Deepak L. Bhatt, M.D., M.P.H., John P. Kirwan, Ph.D.,

More information

Donna Tomky, MSN, C-ANP, CDE, FAADE Albuquerque, New Mexico

Donna Tomky, MSN, C-ANP, CDE, FAADE Albuquerque, New Mexico Donna Tomky, MSN, C-ANP, CDE, FAADE Albuquerque, New Mexico Presented in Collaboration with New Mexico Health Care Takes On Diabetes Discuss the burden and challenges prediabetes presents in New Mexico.

More information

Risks and benefits of weight loss: challenges to obesity research

Risks and benefits of weight loss: challenges to obesity research European Heart Journal Supplements (2005) 7 (Supplement L), L27 L31 doi:10.1093/eurheartj/sui083 Risks and benefits of weight loss: challenges to obesity research Donna Ryan* Pennington Biomedical Research

More information

The prevalence of obesity in adults has doubled over the past 30 years

The prevalence of obesity in adults has doubled over the past 30 years Obesity in America: Facts and Fiction MICHAEL G. PERRI, PhD Professor, Clinical and Health Psychology Interim Dean, College of Public Health and Health Professions University of Florida Overview: Key Questions

More information

Standards of Care in Diabetes What's New? Veronica Brady, FNP-BC, PhD, BC-ADM,CDE Karmella Thomas, RD, LD,CDE

Standards of Care in Diabetes What's New? Veronica Brady, FNP-BC, PhD, BC-ADM,CDE Karmella Thomas, RD, LD,CDE Standards of Care in Diabetes 2016-- What's New? Veronica Brady, FNP-BC, PhD, BC-ADM,CDE Karmella Thomas, RD, LD,CDE Terminology No longer using the term diabetic. Diabetes does not define people. People

More information

STATE OF THE STATE: TYPE II DIABETES

STATE OF THE STATE: TYPE II DIABETES STATE OF THE STATE: TYPE II DIABETES HENRY DRISCOLL, MD, CHIEF of ENDOCRINOLOGY MARSHALL U, CHERTOW DIABETES CENTER, HUNTINGTON VAMC HEATHER VENOY, RD, LD, CDE DIETITIAN, DIABETES EDUCATOR, CHERTOW DIABETES

More information

Preventing Diabetes K A R O L E. W A T S O N, M D, P H D, F A C C P R O F E S S O R O F M E D I C I N E / C A R D I O L O G Y

Preventing Diabetes K A R O L E. W A T S O N, M D, P H D, F A C C P R O F E S S O R O F M E D I C I N E / C A R D I O L O G Y Preventing Diabetes 2018 K A R O L E. W A T S O N, M D, P H D, F A C C P R O F E S S O R O F M E D I C I N E / C A R D I O L O G Y D A V I D G E F F E N S C H O O L O F M E D I C I N E A T U C L A CO-DIRECTOR,

More information

Impact of bariatric surgery on the management of type 2 diabetes mellitus in Singapore

Impact of bariatric surgery on the management of type 2 diabetes mellitus in Singapore Singapore Med J 2013; 54(7): 382-386 doi: 10.11622/smedj.2013138 Impact of bariatric surgery on the management of type 2 diabetes mellitus in Singapore Phong Ching Lee 1,3, MBChB, MRCP, Kwang Wei Tham

More information

Targeted Nutrition Therapy Nutrition Masters Course

Targeted Nutrition Therapy Nutrition Masters Course Targeted Nutrition Therapy Nutrition Masters Course Nilima Desai, MPH, RD Learning Objectives Review clinical studies on innovative, targeted nutrition therapies for: o Blood glucose management o Dyslipidemia

More information

Type 2 diabetes and metabolic surgery:

Type 2 diabetes and metabolic surgery: Type 2 diabetes and metabolic surgery: Shouldn't we call it again again bariatric? Josep Vidal Obesity Unit. Endocrinology and Nutrition Department Hospital Clínic, University of Barcelona (Spain) What

More information

Innovate. Discover. Cure. Type 2 Diabetes what you and your family need to know

Innovate. Discover. Cure. Type 2 Diabetes what you and your family need to know 1 Innovate. Discover. Cure. Type 2 Diabetes what you and your family need to know Opening comments Steven R. Smith, MD Founding Scientific Director - TRI Professor, metabolic diseases program, Sanford-Burnham

More information

Association of Bariatric Surgery With Long-term Remission of Type 2 Diabetes and With Microvascular and Macrovascular Complications

Association of Bariatric Surgery With Long-term Remission of Type 2 Diabetes and With Microvascular and Macrovascular Complications Research Original Investigation Association of Bariatric Surgery With Long-term Remission of Type 2 Diabetes and With Microvascular and Macrovascular Complications Lars Sjöström, MD, PhD; Markku Peltonen,

More information

Page 2: Baker IDI. Page 4: Baker IDI. Global & Regional Obesity. High income English speaking Light Blue. Global & Regional Severe obesity

Page 2: Baker IDI. Page 4: Baker IDI. Global & Regional Obesity. High income English speaking Light Blue. Global & Regional Severe obesity Metabolic Surgery Update Patients selection and choice of procedure Professor John B Dixon MBBS, FRACGP, FRCP Edin, PhD NHMRC Senior Research Fellow Head of Clinical Obesity Research, Baker IDI Heart and

More information

Weight Management: Obesity to Diabetes

Weight Management: Obesity to Diabetes Weight Management: Obesity to Diabetes Marion J. Franz Nutrition Concepts by Franz, Minneapolis, MN Corresponding author: Marion J. Franz, MarionFranz@aol.com https://doi.org/10.2337/ds17-0011 2017 by

More information

Dr Aftab Ahmad Consultant Diabetologist at Royal Liverpool University Hospital Regional Diabetes Network Lead

Dr Aftab Ahmad Consultant Diabetologist at Royal Liverpool University Hospital Regional Diabetes Network Lead Dr Aftab Ahmad Consultant Diabetologist at Royal Liverpool University Hospital Regional Diabetes Network Lead Today s Presentation HbA1c & diagnosing Diabetes What is Impaired Glucose & IGR? Implications

More information

Non-insulin treatment in Type 1 DM Sang Yong Kim

Non-insulin treatment in Type 1 DM Sang Yong Kim Non-insulin treatment in Type 1 DM Sang Yong Kim Chosun University Hospital Conflict of interest disclosure None Committee of Scientific Affairs Committee of Scientific Affairs Insulin therapy is the mainstay

More information

Chief of Endocrinology East Orange General Hospital

Chief of Endocrinology East Orange General Hospital Targeting the Incretins System: Can it Improve Our Ability to Treat Type 2 Diabetes? Darshi Sunderam, MD Darshi Sunderam, MD Chief of Endocrinology East Orange General Hospital Age-adjusted Percentage

More information

Pre-diabetes. Pharmacological Approaches to Delay Progression to Diabetes

Pre-diabetes. Pharmacological Approaches to Delay Progression to Diabetes Pre-diabetes Pharmacological Approaches to Delay Progression to Diabetes Overview Definition of Pre-diabetes Risk Factors for Pre-diabetes Clinical practice guidelines for diabetes Management, including

More information

Obesity Management in Type 2 Diabetes

Obesity Management in Type 2 Diabetes Obesity Management in Type 2 Diabetes Clare J. Lee, MD, MHS Assistant Professor of Medicine, Division of Endocrinology, Diabetes & Metabolism, Johns Hopkins University Disclosures None Objectives Describe

More information

Goals of today s talk. How to Stop Prediabetes from Becoming Diabetes. Goals of today s talk. Type 2 diabetes mellitus

Goals of today s talk. How to Stop Prediabetes from Becoming Diabetes. Goals of today s talk. Type 2 diabetes mellitus Goals of today s talk How to Stop Prediabetes from Becoming Diabetes Zara Frankel, MD Boulder Creek Family Medicine 303-720-6956 Diabetes is a devastating disease Prediabetes and diabetes are on different

More information

Bariatric Surgery Update

Bariatric Surgery Update Bariatric Surgery Update Alexander Perez, MD, FACS Professor of Surgery Chief, Division Minimally Invasive and Foregut Surgery Speaker Disclosure Dr. Perez has disclosed that the has no actual or potential

More information

Effect of Bariatric Surgery on Cardio-Metabolic Outcomes

Effect of Bariatric Surgery on Cardio-Metabolic Outcomes Effect of Bariatric Surgery on Cardio-Metabolic Outcomes Disclosure Research support from Bariatric Advantage (supplements donated for research study) Anne Schafer, MD Associate Professor of Medicine and

More information

Supplementary Appendix

Supplementary Appendix Supplementary Appendix This appendix has been provided by the authors to give readers additional information about their work. Supplement to: Schauer PR, Kashyap SR, Wolski K, et al. Bariatric surgery

More information

Objectives 10/11/2013. Diabetes- The Real Cost of Sugar. Diabetes 101: What is Diabetes. By Ruth Nekonchuk RD CDE LMNT

Objectives 10/11/2013. Diabetes- The Real Cost of Sugar. Diabetes 101: What is Diabetes. By Ruth Nekonchuk RD CDE LMNT Diabetes- The Real Cost of Sugar By Ruth Nekonchuk RD CDE LMNT Objectives To explain diabetes To explain the risks of diabetes To enumerate the cost of diabetes to our country To enumerate the cost of

More information

Current Status of Bariatric Surgery in Asia

Current Status of Bariatric Surgery in Asia Emerald hall A, 1:2-1:5, November 7, 213 Current Status of Bariatric Surgery in Asia Go Wakabayashi, MD, PhD, FACS Professor and Chairman Department of Surgery Iwate Medical University Numbers of bariatric

More information

Diabetes and Weight Management: Tools to Affect Patient Outcomes

Diabetes and Weight Management: Tools to Affect Patient Outcomes Diabetes and Weight Management: Tools to Affect Patient Outcomes Today s discussion Review the problem of diabetes and the importance of lifestyle intervention Identify current research supporting the

More information

Chairman s Rounds, 02/15/2011

Chairman s Rounds, 02/15/2011 Chairman s Rounds, 02/15/2011 Edward Lipkin, MD Associate Professor, Department of Medicine Division of Metabolism, Endocrinology and Nutrition University of Washington Predictive factors in patient s

More information

OBESITY: The Growing Epidemic and its Medical Impact

OBESITY: The Growing Epidemic and its Medical Impact OBESITY: The Growing Epidemic and its Medical Impact Ray Plodkowski, MD Co-Chief, Chief, of Division of Medical Nutrition, University of Nevada School of Medicine. Chief, Endocrinology & Metabolism, Sachiko

More information

* Assit. prof., *** Prof. & Head of deptt., Deptt. of Surgery, MGIMS ** Asstt prof Deptt. of Medicine. REVIEW ARTICLE

* Assit. prof., *** Prof. & Head of deptt., Deptt. of Surgery, MGIMS ** Asstt prof Deptt. of Medicine. REVIEW ARTICLE REVIEW ARTICLE TYPE 2 DIABETES MELLITUS - EXPLORING THE AVENUE OF BARIATRIC SURGERY. S RAO*, JAIN VV**, GUPTA DO***. Diabetes is a growing public health problem world-wide and especially in India which

More information

OBESITY:Pharmacotherapy Vs Surgery

OBESITY:Pharmacotherapy Vs Surgery OBESITY:Pharmacotherapy Vs Surgery Dr. Ranajit Sen Chowdhury Associate Professor Department of Medicine Sir Salimullah Medical College & Mitford Hospital. 1 Historical Perspective Paleolithic Era > 25,000

More information

Page 2: Baker IDI. Page 4: Baker IDI. Global & Regional Obesity. High income English speaking Light Blue. Global & Regional Severe obesity

Page 2: Baker IDI. Page 4: Baker IDI. Global & Regional Obesity. High income English speaking Light Blue. Global & Regional Severe obesity Metabolic Update Patients selection and choice of procedure Professor John B Dixon MBBS, FRACGP, FRCP Edin, PhD NHMRC Senior Research Fellow Head of Clinical Obesity Research, Baker IDI Heart and Diabetes

More information

Hypertension and obesity. Dr Wilson Sugut Moi teaching and referral hospital

Hypertension and obesity. Dr Wilson Sugut Moi teaching and referral hospital Hypertension and obesity Dr Wilson Sugut Moi teaching and referral hospital No conflict of interests to declare Obesity Definition: excessive weight that may impair health BMI Categories Underweight BMI

More information

Elevated Serum Levels of Adropin in Patients with Type 2 Diabetes Mellitus and its Association with

Elevated Serum Levels of Adropin in Patients with Type 2 Diabetes Mellitus and its Association with Elevated Serum Levels of Adropin in Patients with Type 2 Diabetes Mellitus and its Association with Insulin Resistance Mehrnoosh Shanaki, Ph.D. Assistant Professor of Clinical Biochemistry Shahid Beheshti

More information

10/16/2014. Normal Weight: BMI Overweight: BMI >25 Obese: BMI >30 Morbidly Obese: BMI >40 or >35 with 2 comorbidities

10/16/2014. Normal Weight: BMI Overweight: BMI >25 Obese: BMI >30 Morbidly Obese: BMI >40 or >35 with 2 comorbidities Brinton Clark, MD, MPH Department of Medical Education Providence Portland Medical Center October 25 th, 2014 Oregon Society of Physician Assistants Fall Conference 45 yo woman with BMI=40kg/m2 (weight

More information

Standards of Medical Care in Diabetes 2016

Standards of Medical Care in Diabetes 2016 Standards of Medical Care in Diabetes 2016 Care Delivery Systems 33-49% of patients still do not meet targets for A1C, blood pressure, or lipids. 14% meet targets for all A1C, BP, lipids, and nonsmoking

More information

Subject Index. postprandial glycemia and suppression in serum 51 recommendations 119, 120 supplementation pros and cons 118, 119

Subject Index. postprandial glycemia and suppression in serum 51 recommendations 119, 120 supplementation pros and cons 118, 119 Acarbose, diabetes prevention trials 32, 33, 40 42 Accelerator hypothesis accelerators beta cell autoimmunity 140, 141, 147, 150, 151 insulin resistance 140, 142 144, 150 obesity 145 148 diabetes risk

More information

Clinical Practice Guidelines for the Metabolic and Nonsurgical Support of the Bariatric Surgery Patient-2014 Update

Clinical Practice Guidelines for the Metabolic and Nonsurgical Support of the Bariatric Surgery Patient-2014 Update Clinical Practice Guidelines for the Metabolic and Nonsurgical Support of the Bariatric Surgery Patient-2014 Update 1.Introduction Obesity continues to be a major public health problem in Belgium, with

More information

Gestational Diabetes: Long Term Metabolic Consequences. Outline 5/27/2014

Gestational Diabetes: Long Term Metabolic Consequences. Outline 5/27/2014 Gestational Diabetes: Long Term Metabolic Consequences Gladys (Sandy) Ramos, MD Associate Clinical Professor Maternal Fetal Medicine Outline Population rates of obesity and T2DM Obesity and metabolic syndrome

More information

Metabolic Syndrome. Shon Meek MD, PhD Mayo Clinic Florida Endocrinology

Metabolic Syndrome. Shon Meek MD, PhD Mayo Clinic Florida Endocrinology Metabolic Syndrome Shon Meek MD, PhD Mayo Clinic Florida Endocrinology Disclosure No conflict of interest No financial disclosure Does This Patient Have Metabolic Syndrome? 1. Yes 2. No Does This Patient

More information

Lifestyle Medicine. This presentation will:

Lifestyle Medicine. This presentation will: Lifestyle Medicine This presentation will: Identify barriers to lifestyle therapy and develop strategies to promote behavioral changes in patients with obesity and/or T2D. AACE = American Association of

More information

Developing nations vs. developed nations Availability of food contributes to overweight and obesity

Developing nations vs. developed nations Availability of food contributes to overweight and obesity KNH 406 1 Developing nations vs. developed nations Availability of food contributes to overweight and obesity Intake Measured in kilojoules (kj) or kilocalories (kcal) - food energy Determined by bomb

More information

Bariatric Surgery MM /11/2001. HMO; PPO; QUEST 05/01/2012 Section: Surgery Place(s) of Service: Outpatient; Inpatient

Bariatric Surgery MM /11/2001. HMO; PPO; QUEST 05/01/2012 Section: Surgery Place(s) of Service: Outpatient; Inpatient Bariatric Surgery Policy Number: Original Effective Date: MM.06.003 09/11/2001 Line(s) of Business: Current Effective Date: HMO; PPO; QUEST 05/01/2012 Section: Surgery Place(s) of Service: Outpatient;

More information

Commonly Performed Bariatric Procedures in Singapore. Lin Jinlin Associate Consultant General, Upper GI and Bariatric Surgery Changi General Hospital

Commonly Performed Bariatric Procedures in Singapore. Lin Jinlin Associate Consultant General, Upper GI and Bariatric Surgery Changi General Hospital Commonly Performed Bariatric Procedures in Singapore Lin Jinlin Associate Consultant General, Upper GI and Bariatric Surgery Changi General Hospital Scope 1. Introduction 2. Principles of bariatric surgery

More information

Five Things a Family Physician Needs to Know about Baritric Surgery.

Five Things a Family Physician Needs to Know about Baritric Surgery. Five Things a Family Physician Needs to Know about Baritric Surgery. Dr. J Kenneth Reed MD FRCS(C) Guelph General Bariatric Centre of Excellence May 2014 Five Things to Know About Bariatric Surgery Presenter

More information

Bariatric Surgery Update

Bariatric Surgery Update Friday General Session Bariatric Surgery Update Alex Perez, MD Chief, Division of Minimally Invasive and Foregut Surgery James E. Thompson, MD Family Distinguished Professor in Surgical Simulation Co Director,

More information

Nutritional Aspects of Obesity Management. Christy Olson MS, RD, LD, CDE

Nutritional Aspects of Obesity Management. Christy Olson MS, RD, LD, CDE Nutritional Aspects of Obesity Management Christy Olson MS, RD, LD, CDE Relevant Disclosure and Resolution Under Accreditation Council for Continuing Medical Education guidelines disclosure must be made

More information

A SYSTEMATIC APPROACH TO

A SYSTEMATIC APPROACH TO A SYSTEMATIC APPROACH TO OBESITY Robert B. Baron MD MS Professor and Associate Dean UCSF School of Medicine Declaration of full disclosure: No conflict of interest Prevalence of Obesity (Adults): 2008

More information

The Metabolic Syndrome: Is It A Valid Concept? YES

The Metabolic Syndrome: Is It A Valid Concept? YES The Metabolic Syndrome: Is It A Valid Concept? YES Congress on Diabetes and Cardiometabolic Health Boston, MA April 23, 2013 Edward S Horton, MD Joslin Diabetes Center Harvard Medical School Boston, MA

More information

Diabetes Head To Toe May 31, Obesity in Canada. Six million Canadians are living with obesity

Diabetes Head To Toe May 31, Obesity in Canada. Six million Canadians are living with obesity Medical & Surgical Options for the Bariatric Patient Michelle Mountain, RD, B.Sc Obesity in Canada 1 in 5 adults are obese Six million Canadians are living with obesity 1 in 10 children have clinical obesity

More information

Objectives. Medical Nutrition Therapy (MNT) for Diabetes Evidence-based Recommendations. No financial disclosures

Objectives. Medical Nutrition Therapy (MNT) for Diabetes Evidence-based Recommendations. No financial disclosures Medical Nutrition Therapy (MNT) for Diabetes Evidence-based Recommendations Advances in Internal Medicine 2013 Sarah Kim, MD Assistant Clinical Professor, UCSF-SFGH No financial disclosures Objectives

More information

Prevent Diabetes STAT Hannah Herold, MPH, MA, CHES Chronic Disease Prevention Program Wyoming Department of Health Partnering with Wyoming Primary

Prevent Diabetes STAT Hannah Herold, MPH, MA, CHES Chronic Disease Prevention Program Wyoming Department of Health Partnering with Wyoming Primary Prevent Diabetes STAT Hannah Herold, MPH, MA, CHES Chronic Disease Prevention Program Wyoming Department of Health Partnering with Wyoming Primary Care Association Objectives Understand the prevalence

More information

Bariatric Surgery vs. Intensive Medical Therapy in Obese Diabetic Patients. Results of the STAMPEDE Trial

Bariatric Surgery vs. Intensive Medical Therapy in Obese Diabetic Patients. Results of the STAMPEDE Trial ariatric Surgery vs. Intensive Medical Therapy in Obese Diabetic atients Results of the STAMEDE Trial R Schauer, SR Kashyap, K Wolski, SA rethauer, Kirwan, CE othier, S Thomas, Abood, SE Nissen and DL

More information

Metabolic Syndrome Update The Metabolic Syndrome: Overview. Global Cardiometabolic Risk

Metabolic Syndrome Update The Metabolic Syndrome: Overview. Global Cardiometabolic Risk Metabolic Syndrome Update 21 Marc Cornier, M.D. Associate Professor of Medicine Division of Endocrinology, Metabolism & Diabetes University of Colorado Denver Denver Health Medical Center The Metabolic

More information

Lecture Goals. Body Mass Index. Obesity Definitions. Bariatric Surgery What the PCP Needs to Know 11/17/2009. Indications for bariatric Surgeries

Lecture Goals. Body Mass Index. Obesity Definitions. Bariatric Surgery What the PCP Needs to Know 11/17/2009. Indications for bariatric Surgeries Bariatric Surgery What the PCP Needs to Know Mouna Abouamara Assistant Professor Internal Medicine James H Quillen College Of Medicine Lecture Goals Indications for bariatric Surgeries Different types

More information

ENTRY CRITERIA: C. Approved Comorbidities: Diabetes

ENTRY CRITERIA: C. Approved Comorbidities: Diabetes KAISER PERMANENTE OHIO BARIATRIC SURGERY (GASTROPLASTY) Methodology: Expert Opinion Issue Date: 12-05 Champion: Surgery Review Date: 4-10, 4-12 Key Stakeholders: Surgery, IM Depts. Next Update: 4-14 RELEVANCE:

More information

Zia H Shah MD FCCP. Director of Sleep Lab Our Lady Of Lourdes Hospital, Binghamton

Zia H Shah MD FCCP. Director of Sleep Lab Our Lady Of Lourdes Hospital, Binghamton Zia H Shah MD FCCP Director of Sleep Lab Our Lady Of Lourdes Hospital, Binghamton Obesity 70-80% of cases Alcohol use Hypognathism Marfan s syndrome Smoking ENT problems OSA and DM epidemics have

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Larsen JR, Vedtofte L, Jakobsen MSL, et al. Effect of liraglutide treatment on prediabetes and overweight or obesity in clozapine- or olanzapine-treated patients with schizophrenia

More information

Objectives. Objectives. Alejandro J. de la Torre, MD Cook Children s Hospital May 30, 2015

Objectives. Objectives. Alejandro J. de la Torre, MD Cook Children s Hospital May 30, 2015 Alejandro J. de la Torre, MD Cook Children s Hospital May 30, 2015 Presentation downloaded from http://ce.unthsc.edu Objectives Understand that the obesity epidemic is also affecting children and adolescents

More information

What s New in Bariatric Surgery?

What s New in Bariatric Surgery? Bariatric Surgery: Update for the General Surgeon What s New in Bariatric Surgery? 2,000 B.C. 2,000 A.D. 1. America keeps getting fatter without an end in sight. 2. Bariatric surgery is not just about

More information

Alcohol Consumption and Alcohol Problems After Bariatric Surgery in the Swedish Obese Subjects Study

Alcohol Consumption and Alcohol Problems After Bariatric Surgery in the Swedish Obese Subjects Study Alcohol Consumption and Alcohol Problems After Bariatric Surgery in the Swedish Obese Subjects Study Per-Arne Svensson 1,A sa Anveden 1, Stefano Romeo 1, Markku Peltonen 1,2, Sofie Ahlin 1, Maria Antonella

More information

Diabetes control and lessened cerebral cardiovascular risks after gastric bypass surgery in Asian Taiwanese with a body mass index <35 kg/m2

Diabetes control and lessened cerebral cardiovascular risks after gastric bypass surgery in Asian Taiwanese with a body mass index <35 kg/m2 Diabetes control and lessened cerebral cardiovascular risks after gastric bypass surgery in Asian Taiwanese with a body mass index

More information

Diabetes Treatment Update

Diabetes Treatment Update Diabetes Treatment Update Timothy C. Evans, MD PhD FACP University of Washington Department of Medicine Disclosure: Dr. Evans has no significant financial interest in any of the products or manufacturers

More information

WELL-WOMAN EXAM REVEALS RISK. Katie Jones, MPH, CHES Iowa Department of Public Health Erin Hinderaker, MS, RD, LD Des Moines University

WELL-WOMAN EXAM REVEALS RISK. Katie Jones, MPH, CHES Iowa Department of Public Health Erin Hinderaker, MS, RD, LD Des Moines University WELL-WOMAN EXAM REVEALS RISK Katie Jones, MPH, CHES Iowa Department of Public Health Erin Hinderaker, MS, RD, LD Des Moines University Disclaimer The information provided in this presentation is for informational

More information

Effect of macronutrients and mixed meals on incretin hormone secretion and islet cell function

Effect of macronutrients and mixed meals on incretin hormone secretion and islet cell function Effect of macronutrients and mixed meals on incretin hormone secretion and islet cell function Background. Following meal ingestion, several hormones are released from the gastrointestinal tract. Some

More information

Implementing Type 2 Diabetes Prevention Programmes

Implementing Type 2 Diabetes Prevention Programmes Implementing Type 2 Diabetes Prevention Programmes Jaakko Tuomilehto Department of Public Health University of Helsinki Helsinki, Finland FIN-D2D Survey 2004 Prevalence of previously diagnosed and screen-detected

More information

Bariatric surgery: Impact on Co-morbidities and Weight Loss Expectations ALIYAH KANJI, MD FRCSC MIS AND BARIATRIC SURGERY SEPTEMBER 22, 2018

Bariatric surgery: Impact on Co-morbidities and Weight Loss Expectations ALIYAH KANJI, MD FRCSC MIS AND BARIATRIC SURGERY SEPTEMBER 22, 2018 Bariatric surgery: Impact on Co-morbidities and Weight Loss Expectations ALIYAH KANJI, MD FRCSC MIS AND BARIATRIC SURGERY SEPTEMBER 22, 2018 Disclosures None Objectives Review expected weight loss from

More information

Welcome and Introduction

Welcome and Introduction Welcome and Introduction This presentation will: Define obesity, prediabetes, and diabetes Discuss the diagnoses and management of obesity, prediabetes, and diabetes Explain the early risk factors for

More information

Short-Term Insulin Requirements Following Gastric Bypass Surgery in Severely Obese Women with Type 1 Diabetes

Short-Term Insulin Requirements Following Gastric Bypass Surgery in Severely Obese Women with Type 1 Diabetes Short-Term Insulin Requirements Following Gastric Bypass Surgery in Severely Obese Women with Type 1 Diabetes The Harvard community has made this article openly available. Please share how this access

More information

DISCLOSURE STATEMENT

DISCLOSURE STATEMENT Challenging Cases in Obesity Management Jonathan Q. Purnell, MD Knight Cardiovascular Institute Division of Endocrinology Oregon Health & Science University DISCLOSURE STATEMENT Speaker: Jonathan Q. Purnell,

More information

Management of Obesity. Objectives. Background Impact and scope of Obesity. Control of Energy Homeostasis Methods of treatment Medications.

Management of Obesity. Objectives. Background Impact and scope of Obesity. Control of Energy Homeostasis Methods of treatment Medications. Medical Management of Obesity Ben O Donnell, MD 1 Objectives Background Impact and scope of Obesity Control of Energy Homeostasis Methods of treatment Medications 2 O'Donnell 1 Impact of Obesity According

More information

Bariatric Surgery: A Cost-effective Treatment of Obesity?

Bariatric Surgery: A Cost-effective Treatment of Obesity? Bariatric Surgery: A Cost-effective Treatment of Obesity? Shaneeta M. Johnson MD FACS FASMBS 2018 NMA Professional Development Seminar Congressional Black Caucus Foundation Annual Legislative Conference

More information

6/23/2011. Bariatric Surgery: What the Primary Care Provider Should Know. Case Presentation: Rachelle

6/23/2011. Bariatric Surgery: What the Primary Care Provider Should Know. Case Presentation: Rachelle Bariatric Surgery: What the Primary Care Provider Should Know 2,000 B.C. 2,000 A.D. Case Presentation: Rachelle 35 year-old woman with morbid obesity. 5 1 236 lbs BMI 44.5 PMHx: mild depression obstructive

More information

Diabetes and Weight in Comparative Studies of Bariatric Surgery vs Conventional Medical Therapy: A Systematic Review and Meta-Analysis

Diabetes and Weight in Comparative Studies of Bariatric Surgery vs Conventional Medical Therapy: A Systematic Review and Meta-Analysis OBES SURG (2014) 24:437 455 DOI 10.1007/s11695-013-1160-3 REVIEW ARTICLE Diabetes and Weight in Comparative Studies of Bariatric Surgery vs Conventional Medical Therapy: A Systematic Review and Meta-Analysis

More information

Goals 1/9/2018. Obesity over the last decade Surgery has become a safer management strategy Surgical options for management

Goals 1/9/2018. Obesity over the last decade Surgery has become a safer management strategy Surgical options for management The Current State of Surgical Intervention in Management of Morbid Obesity Goals Obesity over the last decade Surgery has become a safer management strategy Surgical options for management 1 Goals Obesity

More information

The Metabolic Syndrome Update The Metabolic Syndrome Update. Global Cardiometabolic Risk

The Metabolic Syndrome Update The Metabolic Syndrome Update. Global Cardiometabolic Risk The Metabolic Syndrome Update 2018 Marc Cornier, M.D. Professor of Medicine Division of Endocrinology, Metabolism & Diabetes Anschutz Health and Wellness Center University of Colorado School of Medicine

More information

Obesity Prevention and Control: Provider Education with Patient Intervention

Obesity Prevention and Control: Provider Education with Patient Intervention Obesity Prevention and : Provider Education with Patient Summary Evidence Table and Population Cohen et al. (1991) 1987-1988 : RCT Location: Pittsburgh, PA Physician training session by a behavioral psychologist

More information

Overview of Evidence-Based Strategies to Address Your Weight. Obesity Treatment Pyramid

Overview of Evidence-Based Strategies to Address Your Weight. Obesity Treatment Pyramid Overview of Evidence-Based Strategies to Address Your Weight Domenica M. Rubino, MD Obesity Treatment Pyramid Individual Circumstances & BMI and Co-morbid conditions 1 What can I do on my own? About ½

More information

Session 6B Appropriate Treatment of Obesity Demonstrates Clinical & Economic Success

Session 6B Appropriate Treatment of Obesity Demonstrates Clinical & Economic Success Session 6B Appropriate Treatment of Obesity Demonstrates Clinical & Economic Success Part 2 John Dawson, FSA, MAAA Appropriate Treatment of Obesity Demonstrates Clinical & Economic Success SOA Asia-Pacific

More information

MTE 4 and 9 Macronutrient Mix: Ideal Intake vs. Real-World Eating? References:

MTE 4 and 9 Macronutrient Mix: Ideal Intake vs. Real-World Eating? References: MTE 4 and 9 Macronutrient Mix: Ideal Intake vs. Real-World Eating? Bayview Room, Bay Level Marion J. Franz, MS, RDN, CDE Saturday, March 5, 2016 2:00 p.m. 3:30 p.m. and 3:45 p.m. 5:15 p.m. Research trials

More information

Viriato Fiallo, MD Ursula McMillian, MD

Viriato Fiallo, MD Ursula McMillian, MD Viriato Fiallo, MD Ursula McMillian, MD Objectives Define obesity and effects on society and healthcare Define bariatric surgery Discuss recent medical management versus surgery research Evaluate different

More information

Surgery recommendations based on BMI and glycemic control

Surgery recommendations based on BMI and glycemic control Surgery recommendations based on BMI and glycemic control BMI (kg/m2) in type 2 diabetes patients Glycemic control Surgery guidelines 40+ (37.5+ in Asian Americans) Controlled or uncontrolled Recommended

More information